Skip to contentB
Biomerica Inc
B
BMRABiomerica Inc Q1 2026 · 10-Q
Revenue$1.38M$1.38M−23.6% vs Q1 2025 Net Income$2.00K$2.00KN/M vs Q1 2025 EPS Diluted$0.00$0.00N/M vs Q1 2025 Gross Profit$424,000+46.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biomerica Inc · CIK 73290 · Engraved from SEC EDGAR
Operating Cash Flow-$268,000N/M Margins · derivedGross margin30.7%+14.7 pt vs Q1 2025
Operating margin-81.0%−5.3 pt vs Q1 2025
Net margin0.1%+73.0 pt vs Q1 2025
ended Aug 31, 2025 · filed Oct 14, 2025 · 44 d after period end